Case Time! V.T. Edwards: Management of Extended Thromboprophylaxis in the Medically Ill
Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
What Options Are Available Prophylactically for My Acute and Post-Acute Medically Ill Patients?
Alfonso J. Tafur, MD, MS, MBA, RPVI
Primary Prevention, Initial Treatment & Management of VTE, Secondary VTE Prevention Strategies
Bruce L. Davidson, MD, MPH
Scott Kaatz, DO, MSc, FACP, SFHM
Deborah Siegal, MD, MSc, FRCPC
Victor F. Tapson, MD
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
Right from the Onset: DVT Diagnosis, Management
Impact of Social Determinants of Health on Management of AF
Kevin Thomas, MD
ACC/AHA/ACCP/HRS Guideline Updates in the Management of Atrial Fibrillation
Manesh R. Patel, MD
Sean Pokorney, MD
Mina K. Chung, MD
How Do We Best Incorporate Latest Guidance in Optimizing Care for the Patient with AF?
What Are the Latest Updates on the Clinical and Economic Impact of AF?
AF Screening, Risk Factors, and Diagnosis: What’s New?
Latest Guidance on Anticoagulation in AF Patient Populations with Comorbidities
Stroke Management of the Future? The Potential Role of Factor XI/XIa Inhibitors in Secondary Stroke Prevention
Valeria Caso, MD, PhD
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
While Antiplatelets Are Good…They Aren’t for Everyone
The Case of Arthur Frank: How Do We Manage Elderly Patients with Atrial Fibrillation?
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We’re glad to see you’re enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.